United States Peripheral Vascular Devices Market Outlook to 2036 – Arteriotomy Closure Devices, Peripheral Embolic Protection Devices, Venous Stents and Others

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

$4995
Buy Report Download FREE Resources

Published: April 27, 2026 Report Code: GDME5078CCDB-ST

Select Item

GlobalData’s “United States Peripheral Vascular Devices Outlook to 2036” is a comprehensive databook report, covering key market data on the United States Peripheral Vascular Devices market. The databook report provides value (USD), volume (units) and average prices (USD) within market segments – Arteriotomy Closure Devices, Peripheral Embolic Protection Devices, Peripheral Accessories, Peripheral Vascular Stents, Carotid and Renal Artery Stents, Renal Denervation Catheters, PTA Balloon Catheters, Vascular Embolization Plugs and Coils, Venous Stents and Superficial Vein Devices

The United States Peripheral Vascular Devices Market report provides key information and data on:
• Annualized market revenues (USD), volume (units) and average prices (USD) data for each of the market segments. Data is provided from 2024 to 2036.
• 2025 company share data for Peripheral Vascular Devices Market.
• Global corporate-level profiles of key companies operating within the United States Peripheral Vascular Devices Market. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is also available in the report.

Scope

United States Peripheral Vascular Devices is segmented as follows:

• Arteriotomy Closure Devices

• Peripheral Embolic Protection Devices

• Peripheral Accessories

• Peripheral Vascular Stents

• Carotid and Renal Artery Stents

• Renal Denervation Catheters

• PTA Balloon Catheters

• Vascular Embolization Plugs and Coils

• Venous Stents

• Superficial Vein Devices

Reasons to Buy

The United States Peripheral Vascular Devices Market report helps you to develop:

• Business strategies by identifying the key market segments poised for strong growth in the future.

• Market-entry and market expansion strategies.

• Design competition strategies by identifying who-stands-where in the market.

• Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.

• Understand the key distribution channels and what’s the most preferred mode of product distribution – Identify, understand and capitalize.

Table of Contents

Table of Contents

List of Tables

List of Figures

1 Introduction

1.1 What Is This Report About?

1.2 Peripheral Vascular Devices Market Segmentation

1.3 Definitions of Markets Covered in the Report

2 Peripheral Vascular Devices Market, United States

2.1 Peripheral Vascular Devices Market, United States, Revenue ($m), 2024-2036

2.1.1 Arteriotomy Closure Devices Market, United States, Revenue ($m), by Segment, 2024-2036

2.1.2 Carotid and Renal Artery Stents Market, United States, Revenue ($m), by Segment, 2024-2036

2.1.3 Peripheral Accessories Market, United States, Revenue ($m), by Segment, 2024-2036

2.1.4 Peripheral Embolic Protection Devices Market, United States, Revenue ($m), by Segment, 2024-2036

2.1.5 Peripheral Vascular Stents Market, United States, Revenue ($m), by Segment, 2024-2036

2.1.6 PTA Balloon Catheters Market, United States, Revenue ($m), by Segment, 2024-2036

2.1.7 Renal Denervation Catheters Market, United States, Revenue ($m), by Segment, 2024-2036

2.1.8 Superficial Vein Devices Market, United States, Revenue ($m), by Segment, 2024-2036

2.1.9 Vascular Embolization Plugs and Coils Market, United States, Revenue ($m), by Segment, 2024-2036

2.2 Peripheral Vascular Devices Market, United States, Volume (Units), 2024-2036

2.2.1 Arteriotomy Closure Devices Market, United States, Volume (Units), by Segment, 2024-2036

2.2.2 Carotid and Renal Artery Stents Market, United States, Volume (Units), by Segment, 2024-2036

2.2.3 Peripheral Accessories Market, United States, Volume (Units), by Segment, 2024-2036

2.2.4 Peripheral Embolic Protection Devices Market, United States, Volume (Units), by Segment, 2024-2036

2.2.5 Peripheral Vascular Stents Market, United States, Volume (Units), by Segment, 2024-2036

2.2.6 PTA Balloon Catheters Market, United States, Volume (Units), by Segment, 2024-2036

2.2.7 Renal Denervation Catheters Market, United States, Volume (Units), by Segment, 2024-2036

2.2.8 Superficial Vein Devices Market, United States, Volume (Units), by Segment, 2024-2036

2.2.9 Vascular Embolization Plugs and Coils Market, United States, Volume (Units), by Segment, 2024-2036

2.3 Peripheral Vascular Devices Market, United States, Average Price ($), 2024-2036

2.4 Peripheral Vascular Devices Market, United States, Company Share by Revenue ($m), 2025

3 Peripheral Vascular Devices Market Pipeline Products

3.1 Peripheral Vascular Devices Market Pipeline Products

3.2 Peripheral Vascular Devices – Pipeline Products by Stage of Development

3.3 Peripheral Vascular Devices – Pipeline Products by Segment

3.4 Peripheral Vascular Devices – Pipeline Products by Territory

3.5 Peripheral Vascular Devices – Pipeline Products by Regulatory Path

3.6 Peripheral Vascular Devices – Pipeline Products by Estimated Approval Date

4 Overview of Key Companies in United States, Peripheral Vascular Devices Market

4.1 Medtronic Plc

4.1.1 Company Overview

4.2 W. L. Gore & Associates Inc

4.2.1 Company Overview

4.3 Abbott Laboratories

4.3.1 Company Overview

4.4 Boston Scientific Corp

4.4.1 Company Overview

4.5 Terumo Corp

4.5.1 Company Overview

4.6 Becton Dickinson and Co

4.6.1 Company Overview

4.7 Shockwave Medical Inc

4.7.1 Company Overview

4.8 Penumbra Inc

4.8.1 Company Overview

4.9 Silk Road Medical Inc

4.9.1 Company Overview

4.10 Cordis Corp

4.10.1 Company Overview

5 Recent Developments

5.1 Corporate Communications

5.1.1 Apr 07, 2026: TriSalus Life Sciences Appoints Richard Marshall, M.D., as Chief Medical Officer

5.1.2 Jan 08, 2026: Merit Medical Appoints F. Ann Millner as Chair of the Board and Provides Preliminary Q4 2025 Revenue Range

5.1.3 Nov 25, 2025: SNF Agora Institute at Johns Hopkins Begins Search for Next Director

5.1.4 Nov 21, 2025: Johnson & Johnson Signs National Charter for Mental Health at Work

5.1.5 Nov 21, 2025: Daniel Weiss to Leave Johns Hopkins to Lead Philadelphia Art Museum

5.1.6 Nov 17, 2025: BD Appoints Robert Huffines And Jacqueline Wright To Board Of Directors

5.1.7 Nov 17, 2025: Biomedix Welcomes New VP of Customer Success and Growth

5.1.8 Nov 06, 2025: RenovoRx Appoints Pancreatic Cancer Expert Timothy Donahue, MD, to Scientific Advisory Board

5.1.9 Nov 06, 2025: Applications Open For Catalyst And Discovery Awards

5.1.10 Nov 01, 2025: Dale Medical Products, Inc. Introduces IV Line Manager

5.1.11 Oct 30, 2025: VentureMed Group Closes $28 Million Series C Financing to Accelerate Commercial Adoption and Expand Indications for FLEX VPTM System

5.1.12 Oct 30, 2025: Edwards Lifesciences CFO Transition Plan Announced

5.1.13 Oct 29, 2025: VentureMed Group Secures $28M Series C Funding to Boost FLEX VPTM System Adoption

5.1.14 Oct 24, 2025: Payman Khales Becomes Integer President and CEO

5.1.15 Oct 20, 2025: Committee Tasked With Strategic Planning for JHU's Research Core Facilities

5.1.16 Oct 07, 2025: Jupiter Endovascular Secures Over $40 Million in Series B Financing

5.1.17 Oct 02, 2025: Ontogen Medtech Achieves ISO 13485 Certification Strengthening Contract Manufacturing Capabilities

5.1.18 Oct 01, 2025: Johns Hopkins, Other Large Nonprofits To Double Annual Contribution To Baltimore

5.1.19 Sep 24, 2025: CWSL Alumna Sherry S. Bahrambeygui Elected to UC San Diego Foundation Board

5.1.20 Sep 23, 2025: DJ Babu Joins Peabody Conservatory Hip-Hop Faculty

5.1.21 Sep 08, 2025: UC San Diego Foundation Announces New Trustees

5.1.22 Jul 08, 2025: Medtronic Appoints Chad Spooner as Chief Financial Officer of MiniMed

5.1.23 May 21, 2025: Medtronic Announces Leadership Change in Cardiovascular Portfolio

5.2 Financial Announcements

5.2.1 Apr 02, 2026: Merit Medical Systems to Announce First Quarter 2026 Results on April 30, 2026

5.2.2 Apr 01, 2026: Stryker to Report First-Quarter Fiscal 2026 Results

5.2.3 Mar 30, 2026: RenovoRx Reports Full Year 2025 Financial Results and Provides Business Update

5.2.4 Feb 24, 2026: Merit Medical Reports Fourth Quarter and Full-Year 2025 Results, Provides Fiscal 2026 Guidance

5.2.5 Feb 17, 2026: Teleflex Announces Fourth Quarter 2025 Earnings Conference Call Information

5.2.6 Feb 17, 2026: Teleflex Announces Fourth Quarter 2025 Earnings Conference Call Information

5.2.7 Feb 03, 2026: Edwards Lifesciences to Host Earnings Conference Call on February 10, 2026

5.2.8 Jan 08, 2026: Merit Medical Appoints F. Ann Millner as Chair of the Board and Provides Preliminary Q4 2025 Revenue Range

5.2.9 Nov 14, 2025: Aspira Announces Third Quarter 2025 Financial Results and Provides Business Update

5.2.10 Nov 13, 2025: Catheter Precision Reports Third Quarter and First Nine Months 2025 Results

5.2.11 Nov 06, 2025: Teleflex Reports Third Quarter Financial Results and Full Year 2025 Outlook

5.2.12 Nov 05, 2025: Pulse Biosciences Reports Business Updates and Third Quarter 2025 Financial Results

5.2.13 Oct 27, 2025: RenovoRx to Host Third Quarter 2025 Financial Results and Business Highlights Conference Call

5.2.14 Oct 23, 2025: Edwards Lifesciences to Host Earnings Conference Call on October 30, 2025

5.2.15 Oct 03, 2025: Merit Medical Systems to Announce Third Quarter 2025 Results on October 30, 2025

5.2.16 Oct 02, 2025: AngioDynamics Reports Fiscal Year 2026 First Quarter Financial Results

5.2.17 Sep 25, 2025: Integer Announces Conference Call to Discuss Third Quarter 2025 Results

5.2.18 Sep 02, 2025: Boston Scientific Announces 2025 Investor Day Meeting and Conference Call Discussing Third Quarter 2025 Results

5.2.19 Jul 22, 2025: Semler Scientific Announces Earnings Release Date and Live Video Webinar for Second Quarter 2025 Financial Results

5.2.20 Jul 18, 2025: Edwards Lifesciences to Host Earnings Conference Call on July 24, 2025

5.2.21 Jul 03, 2025: Merit Medical Systems To Announce Second Quarter 2025 Results On July 30, 2025

5.2.22 Jul 03, 2025: Merit Medical Systems To Announce Second Quarter 2025 Results On July 30, 2025

5.2.23 Jul 01, 2025: Penumbra Schedules Second Quarter 2025 Earnings Release and Conference Call for July 29, 2025

5.3 Government and Public Interest

5.3.1 Mar 20, 2026: NHS provides update on supply chain issues following cyber attack on Stryker

5.3.2 Feb 27, 2026: LeMaitre to Participate at Upcoming Investor Conferences in March

5.3.3 Feb 23, 2026: AngioDynamics to Present at the Leerink Partners Global Healthcare Conference

5.3.4 Feb 09, 2026: Johnson & Johnson to Participate in the Barclays 28th Annual Global Healthcare Conference

5.3.5 Dec 22, 2025: AngioDynamics to Present at the 44th Annual J.P. Morgan Healthcare Conference

5.3.6 Nov 11, 2025: TriSalus Life Sciences to Participate in Upcoming Investor Conferences

5.3.7 Nov 03, 2025: Boston Scientific Announces Upcoming Investor Conference Schedule

5.3.8 Oct 27, 2025: RenovoRx to Host Third Quarter 2025 Financial Results and Business Highlights Conference Call

5.3.9 Oct 27, 2025: AngioDynamics to Participate in the UBS Global Healthcare Conference

5.3.10 Sep 25, 2025: Integer Announces Conference Call to Discuss Third Quarter 2025 Results

5.3.11 Aug 20, 2025: Penumbra to Present at Upcoming Investor Conferences

5.3.12 Aug 12, 2025: Integer to Present at 2025 Wells Fargo Healthcare Conference on Sept. 4

5.3.13 Jul 24, 2025: Johnson & Johnson to Participate in the 2025 Wells Fargo Healthcare Conference

5.3.14 Jun 19, 2025: Mah Sing Healthcare Sdn Bhd Receives 510(K) Clearance For Nitrile Powder Free Examination Glove with Tremella Fuciformis Extract

5.3.15 May 01, 2025: Boston Scientific Announces Upcoming Investor Conference Schedule

5.4 Legal And Regulatory

5.4.1 Sep 08, 2025: Shareholders Who Lost Money in Semler Scientific Should Contact Wolf Haldenstein

5.5 Other Significant Developments

5.5.1 Nov 13, 2025: Catheter Precision Reports Third Quarter and First Nine Months 2025 Results

5.5.2 Nov 05, 2025: Pulse Biosciences Reports Business Updates and Third Quarter 2025 Financial Results

5.5.3 Nov 03, 2025: News Updates for Q3 2025

5.5.4 Oct 08, 2025: Linshom Medical Receives 510(K) Clearance For Continuous Predictive Respiratory Monitoring System (CPRMS)

5.5.5 Sep 29, 2025: D. Boral Capital to Host KOL Webinar With World Leading Experts Featuring Insights & Breakthroughs from Enlivex’s Knee Osteoarthritis Program

5.5.6 Sep 08, 2025: Shape Memory Medical Completes Enrollment in EMBO-PMS Registry

5.6 Product News

5.6.1 Apr 09, 2026: TriSalus Life Sciences to Present New Data at the 2026 Society of Interventional Radiology Annual Scientific Meeting

5.6.2 Mar 03, 2026: Arterial IVUS Tutor App Launched in the US to Support IVUS Training

5.6.3 Feb 23, 2026: BD to Present at Barclays 28th Annual Global Healthcare Conference

5.6.4 Jan 28, 2026: Integer to Highlight Integrated R&D Solutions and Expanded Coating Capabilities at MD&M West 2026

5.6.5 Nov 28, 2025: Mike Bako and RENPHO Showcase Health Technology on YourUpdateTV

5.6.6 Nov 19, 2025: Canon Medical Systems USA Introduces Alphenix 4D CT with Aquilion ONE/INSIGHT Edition, Now FDA Cleared

5.6.7 Nov 17, 2025: Terumo Aortic Launches Fenestrated TREO Pivotal IDE Study in the United States

5.6.8 Nov 07, 2025: Gore Announces Positive Clinical Trial Results of the Investigational Gore Viabahn Fortegra Venous Stent for Treatment of Patients with Deep Venous Iliocaval Obstruction

5.6.9 Nov 05, 2025: Pulse Biosciences Reports Business Updates and Third Quarter 2025 Financial Results

5.6.10 Nov 05, 2025: Fluid Control Solutions For MedTech

5.6.11 Nov 04, 2025: AVS Reports Positive Safety and Effectiveness Data from Pulse IVL IDE Study

5.6.12 Nov 04, 2025: Contego Medical Reports 30-Day Outcomes From PERFORMANCE III TCAR-IEP Study

5.6.13 Nov 03, 2025: Johnson & Johnson Confirms Durability of IVL in Complex Below-the-Knee Anatomy

5.6.14 Oct 30, 2025: VentureMed Group Closes $28 Million Series C Financing to Accelerate Commercial Adoption and Expand Indications for FLEX VPTM System

5.6.15 Oct 29, 2025: VentureMed Group Secures $28M Series C Funding to Boost FLEX VPTM System Adoption

5.6.16 Oct 29, 2025: Hyperion Surgical Announces Completion of First-In-Human Study Using Its Ivy Robotic Vascular Access Platform, Achieving World’s First Robotic-Assisted IV Catheterization

5.6.17 Oct 09, 2025: BD Enrolls First Patient in XTRACT Registry for Rotarex Catheter System

5.6.18 Oct 08, 2025: Medical Manufacturing Solutions for Devices and Equipment

5.6.19 Oct 07, 2025: Jupiter Endovascular Secures Over $40 Million in Series B Financing

5.6.20 Sep 08, 2025: Shape Memory Medical Completes Enrollment in EMBO-PMS Registry

5.6.21 Sep 08, 2025: Microbot Medical Receives FDA Clearance for LIBERTY Endovascular Robotic System

5.6.22 Aug 20, 2025: RenovoRx CEO Shaun Bagai To Present at H.C. Wainwright’s 27th Annual Global Investment Conference in New York City, September 8-10, 2025

5.6.23 Jul 01, 2025: MedEdge Innovations Unveils New ePTFE Platform and CDMO Services for Medical Implant Applications

5.7 Strategy And Business Planning

5.7.1 Nov 05, 2025: Microbot Medical Commences Limited Market Release of LIBERTY Endovascular Robotic System in the U.S.

5.7.2 Nov 05, 2025: JLL Partners Announces Combination of Vascular Technology Incorporated and Parks Medical Electronics

5.7.3 Sep 11, 2025: Penumbra, Inc. Establishes Manufacturing Plant in Costa Rica

6 Appendix

6.1 Research Methodology

6.1.1 Coverage

6.1.2 Secondary Research

6.1.3 Primary Research

6.1.4 Market Modeling and Forecasting

6.1.5 Company Share Analysis

6.1.6 Benchmarking

6.2 GlobalData Consulting

6.3 Contact Us

6.4 Disclaimer

Table

Table 1: Peripheral Vascular Devices Market, United States, Revenue ($m), USD Constant, 2024-2036

Table 2: Arteriotomy Closure Devices Market, United States, Revenue ($m), USD Constant, 2024-2036

Table 3: Carotid and Renal Artery Stents Market, United States, Revenue ($m), USD Constant, 2024-2036

Table 4: Peripheral Accessories Market, United States, Revenue ($m), USD Constant, 2024-2036

Table 5: Peripheral Embolic Protection Devices Market, United States, Revenue ($m), USD Constant, 2024-2036

Table 6: Peripheral Vascular Stents Market, United States, Revenue ($m), USD Constant, 2024-2036

Table 7: PTA Balloon Catheters Market, United States, Revenue ($m), USD Constant, 2024-2036

Table 8: Renal Denervation Catheters Market, United States, Revenue ($m), USD Constant, 2024-2036

Table 9: Superficial Vein Devices Market, United States, Revenue ($m), USD Constant, 2024-2036

Table 10: Vascular Embolization Plugs and Coils Market, United States, Revenue ($m), USD Constant, 2024-2036

Table 11: Peripheral Vascular Devices Market, United States, Volume (Units), 2024-2036

Table 12: Arteriotomy Closure Devices Market, United States, Volume (Units), 2024-2036

Table 13: Carotid and Renal Artery Stents Market, United States, Volume (Units), 2024-2036

Table 14: Peripheral Accessories Market, United States, Volume (Units), 2024-2036

Table 15: Peripheral Embolic Protection Devices Market, United States, Volume (Units), 2024-2036

Table 16: Peripheral Vascular Stents Market, United States, Volume (Units), 2024-2036

Table 17: PTA Balloon Catheters Market, United States, Volume (Units), 2024-2036

Table 18: Renal Denervation Catheters Market, United States, Volume (Units), 2024-2036

Table 19: Superficial Vein Devices Market, United States, Volume (Units), 2024-2036

Table 20: Vascular Embolization Plugs and Coils Market, United States, Volume (Units), 2024-2036

Table 21: Peripheral Vascular Devices Market, United States, Average Price ($), 2024-2036

Table 22: Peripheral Vascular Devices Market, United States, Company Share by Revenue ($m), USD Constant, 2025

Table 23: Peripheral Vascular Devices Market Pipeline Products

Table 24: Peripheral Vascular Devices – Pipeline Products by Stage of Development

Table 25: Peripheral Vascular Devices Companies – Pipeline Products by Stage of Development

Table 26: Peripheral Vascular Devices – Pipeline Products by Segment

Table 27: Peripheral Vascular Devices – Pipeline Products by Territory

Table 28: Peripheral Vascular Devices – Pipeline Products by Regulatory Path

Table 29: Peripheral Vascular Devices – Pipeline Products by Estimated Approval Date

Table 30: Total Number of Primary Research Participants, Cardiovascular devices Market, by Country

Figures

Figure 1: Peripheral Vascular Devices Market, United States, Revenue ($m), USD Constant, 2024-2036

Figure 2: Arteriotomy Closure Devices Market, United States, Revenue ($m), USD Constant, 2024-2036

Figure 3: Carotid and Renal Artery Stents Market, United States, Revenue ($m), USD Constant, 2024-2036

Figure 4: Peripheral Accessories Market, United States, Revenue ($m), USD Constant, 2024-2036

Figure 5: Peripheral Embolic Protection Devices Market, United States, Revenue ($m), USD Constant, 2024-2036

Figure 6: Peripheral Vascular Stents Market, United States, Revenue ($m), USD Constant, 2024-2036

Figure 7: PTA Balloon Catheters Market, United States, Revenue ($m), USD Constant, 2024-2036

Figure 8: Renal Denervation Catheters Market, United States, Revenue ($m), USD Constant, 2024-2036

Figure 9: Superficial Vein Devices Market, United States, Revenue ($m), USD Constant, 2024-2036

Figure 10: Vascular Embolization Plugs and Coils Market, United States, Revenue ($m), USD Constant, 2024-2036

Figure 11: Peripheral Vascular Devices Market, United States, Volume (Units), 2024-2036

Figure 12: Arteriotomy Closure Devices Market, United States, Volume (Units), 2024-2036

Figure 13: Carotid and Renal Artery Stents Market, United States, Volume (Units), 2024-2036

Figure 14: Peripheral Accessories Market, United States, Volume (Units), 2024-2036

Figure 15: Peripheral Embolic Protection Devices Market, United States, Volume (Units), 2024-2036

Figure 16: Peripheral Vascular Stents Market, United States, Volume (Units), 2024-2036

Figure 17: PTA Balloon Catheters Market, United States, Volume (Units), 2024-2036

Figure 18: Renal Denervation Catheters Market, United States, Volume (Units), 2024-2036

Figure 19: Superficial Vein Devices Market, United States, Volume (Units), 2024-2036

Figure 20: Vascular Embolization Plugs and Coils Market, United States, Volume (Units), 2024-2036

Figure 21: Peripheral Vascular Devices Market, United States, Company Share (%), 2025

Figure 22: Peripheral Vascular Devices – Pipeline Products by Stage of Development

Figure 23: Peripheral Vascular Devices – Pipeline Products by Segment

Figure 24: Peripheral Vascular Devices – Pipeline Products by Territory

Figure 25: Peripheral Vascular Devices – Pipeline Products by Regulatory Path

Figure 26: Peripheral Vascular Devices – Pipeline Products by Estimated Approval Date

United States Peripheral Vascular Devices Market Outlook to 2036 – Arteriotomy Closure Devices, Peripheral Embolic Protection Devices, Venous Stents and Others standard reports
Currency USD
$4,995

Can be used by individual purchaser only

Most Popular
$9,990

Can be shared by unlimited users within one corporate location e.g. a regional office

$14,985

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Add to Basket

Undecided about purchasing this report?

Enquire Before Buying Download FREE Resources

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

Sample Report

United States Peripheral Vascular Devices Market Outlook to 2036 – Arteriotomy Closure Devices, Peripheral Embolic Protection Devices, Venous Stents and Others was curated by the best experts in the industry and we are confident about its unique quality. However, we want you to make the most beneficial decision for your business, so we offer free sample pages to help you:

  • Assess the relevance of the report
  • Evaluate the quality of the report
  • Justify the cost

Download your copy of the sample report and make an informed decision about whether the full report will provide you with the insights and information you need.

Below is a sample report to understand what you are buying

See what our customers are saying
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

 Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

 Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

 Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

 Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

 Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

 Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

 Senior Account Manager, TSYS

Related reports

View more Cardiovascular Devices reports
Medical Devices
New
Medical Devices M&A Deals H1 2026 - Top Themes: Strategic…
$495 | July 2026
Medical Devices
New
AI-designed Materials: Market Trends and Innovations
$995 | July 2026
Medical Devices
New
Traditional Wound Management Market Size by Segments, Share, Regulatory, Reimbursement,…
$7,500 | June 2026
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at United States Peripheral Vascular Devices Market Outlook to 2036 – Arteriotomy Closure Devices, Peripheral Embolic Protection Devices, Venous Stents and Others in real time.

  • Access a live United States Peripheral Vascular Devices Market Outlook to 2036 – Arteriotomy Closure Devices, Peripheral Embolic Protection Devices, Venous Stents and Others dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.
Tell me more